These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37478103)

  • 1. Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19).
    Nicholson BD; Turner PJ; Fanshawe TR; Williams AJ; Amirthalingam G; Tonner S; Zambon M; Body R; Davies K; Perera R; de Lusignan S; Hayward GN; Hobbs FDR;
    PLoS One; 2023; 18(7):e0288612. PubMed ID: 37478103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid community point-of-care testing for COVID-19 (RAPTOR-C19): protocol for a platform diagnostic study.
    Nicholson BD; Hayward G; Turner PJ; Lee JJ; Deeks A; Logan M; Moore A; Seeley A; Fanshawe T; Oke J; Koshiaris C; Sheppard JP; Hoang U; Parimalanathan V; Edwards G; Liyange H; Sherlock J; Byford R; Zambon M; Ellis J; Bernal JL; Amirthalingam G; Linley E; Borrow R; Howsam G; Baines S; Ferreira F; de Lusignan S; Perera R; Hobbs FDR
    Diagn Progn Res; 2021 Feb; 5(1):4. PubMed ID: 33557927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19).
    Fanshawe TR; Tonner S; Turner PJ; Cogdale J; Glogowska M; de Lusignan S; Okusi C; Perera R; Sebastianpillai P; Williams A; Zambon M; Nicholson BD; Hobbs FDR; Hayward GN;
    Clin Microbiol Infect; 2024 Mar; 30(3):380-386. PubMed ID: 38103638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study.
    Venekamp RP; Veldhuijzen IK; Moons KGM; van den Bijllaardt W; Pas SD; Lodder EB; Molenkamp R; Igloi Z; Wijers C; Dos Santos CO; Debast SB; Bruins MJ; Polad K; Nagel-Imming CRS; Han WGH; van de Wijgert JHHM; van den Hof S; Schuit E
    BMC Med; 2022 Feb; 20(1):97. PubMed ID: 35197052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis.
    Fragkou PC; Moschopoulos CD; Dimopoulou D; Ong DSY; Dimopoulou K; Nelson PP; Schweitzer VA; Janocha H; Karofylakis E; Papathanasiou KA; Tsiordras S; De Angelis G; Thölken C; Sanguinetti M; Chung HR; Skevaki C;
    Clin Microbiol Infect; 2023 Mar; 29(3):291-301. PubMed ID: 36336237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
    Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
    J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients.
    Koga P; Maluf M; Nunes F; Campos J; Gazarini L; Borghoff T; Libanori G; Martino M
    Microbiol Spectr; 2022 Oct; 10(5):e0019022. PubMed ID: 36036635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2.
    Krüger LJ; Lindner AK; Gaeddert M; Tobian F; Klein J; Steinke S; Lainati F; Schnitzler P; Nikolai O; Mockenhaupt FP; Seybold J; Corman VM; Jones TC; Pollock NR; Knorr B; Welker A; Weber S; Sethurarnan N; Swaminathan J; Solomon H; Padmanaban A; Thirunarayan M; L P; de Vos M; Ongarello S; Sacks JA; Escadafal C; Denkinger CM
    Microbiol Spectr; 2022 Oct; 10(5):e0122922. PubMed ID: 36066256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
    Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
    Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
    Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
    Young S; Taylor SN; Cammarata CL; Varnado KG; Roger-Dalbert C; Montano A; Griego-Fullbright C; Burgard C; Fernandez C; Eckert K; Andrews JC; Ren H; Allen J; Ackerman R; Cooper CK
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33023911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study.
    Gibani MM; Toumazou C; Sohbati M; Sahoo R; Karvela M; Hon TK; De Mateo S; Burdett A; Leung KYF; Barnett J; Orbeladze A; Luan S; Pournias S; Sun J; Flower B; Bedzo-Nutakor J; Amran M; Quinlan R; Skolimowska K; Herrera C; Rowan A; Badhan A; Klaber R; Davies G; Muir D; Randell P; Crook D; Taylor GP; Barclay W; Mughal N; Moore LSP; Jeffery K; Cooke GS
    Lancet Microbe; 2020 Nov; 1(7):e300-e307. PubMed ID: 32964211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
    Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
    Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.
    Pollock NR; Jacobs JR; Tran K; Cranston AE; Smith S; O'Kane CY; Roady TJ; Moran A; Scarry A; Carroll M; Volinsky L; Perez G; Patel P; Gabriel S; Lennon NJ; Madoff LC; Brown C; Smole SC
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33622768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
    Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
    JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.
    Exner HM; Gregorchuk BSJ; Castor A-G; Crisostomo L; Kolsun K; Giesbrecht S; Dust K; Alexander DC; Bolaji A; Quill Z; Head BM; Meyers AFA; Sandstrom P; Becker MG
    Microbiol Spectr; 2024 Jul; 12(7):e0016324. PubMed ID: 38757955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
    Boum Y; Fai KN; Nikolay B; Mboringong AB; Bebell LM; Ndifon M; Abbah A; Essaka R; Eteki L; Luquero F; Langendorf C; Mbarga NF; Essomba RG; Buri BD; Corine TM; Kameni BT; Mandeng N; Fanne M; Bisseck AZ; Ndongmo CB; Eyangoh S; Hamadou A; Ouamba JP; Koku MT; Njouom R; Claire OM; Esso L; Epée E; Mballa GAE
    Lancet Infect Dis; 2021 Aug; 21(8):1089-1096. PubMed ID: 33773618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.